NAM logo
  • site map
  • contact
  • advanced search
  • Home
  • News
  • Treatment & Care
  • HIV Worldwide
  • Living with HIV
  • Preventing HIV
  • Organisations
  • HIV Basics
  • About Us
 
Treatment & Care
  • español
  • français
  • português
  • pусский
A to Z of drugs
  • Anti-HIV drugs, licensed single class agents
    • Anti-HIV drugs, licensed, fixed-dose combination class
      • Investigational anti-HIV drugs and treatments
        • Other drugs
          • Herbal and naturopathic treatments
            • Discontinued anti-HIV drugs
              • ddC (zalcitabine, Hivid)
            support our work today
            YOU ARE HERE
            • > Home
              • > Treatment & Care
                • > Treatment & Care
                  • > A to Z of drugs

            Discontinued anti-HIV drugs

            printer-friendly versionsend to a friendglossarycomment

            • ddC (zalcitabine, Hivid)

            latest aidsmap news

            • HIV prevalence may decline because the most vulnerable are infected and die first
            • Lack of perceived need for HIV treatment associated with poor adherence
            • TB doesn't always increase HIV viral load
            • New 75mg darunavir tablet approved by FDA for use by HIV-positive children
            • Thyroid checks recommended for people with HIV
            • Knighthood for head of UK HIV charity
            • Gay men often not accessing PEP despite risk of HIV exposure
            • Inflammatory cytokines may contribute to endothelial dysfunction in people with untreated HIV
            • Internalised homophobia leads to sexual risk taking by HIV-positive gay men
            • Most gay men willing to consider PrEP for possible HIV exposure
             
            • Contact NAM
            • Get Email Updates
            • Disclaimer
            • Copyright
            • Developed By NAM